Rx · PZN 19725711

XANAFLU 2025-2026 suspension for injection pre-filled syringe mit needle

German trade nameXANAFLU 2025-2026 Injektionssuspension Fertigspritze mit Kanüle

Active ingredientInfluenza, inactivated, split virus or surface antigenSubstance (DE)Influenza, inaktiviert, Spaltvirus oder OberflächenantigenPharmaceutical formPre-filled syringe

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €102

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for XANAFLU 2025-2026 suspension for injection pre-filled syringe mit needle.

Review purchasing terms

XANAFLU 2025-2026 suspension for injection pre-filled syringe mit needle contains the active ingredient Influenza, inactivated, split virus or surface antigen (German Influenza, inaktiviert, Spaltvirus oder Oberflächenantigen) and comes as Pre-filled syringe. One pack size is recorded (PZN 19725711). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability.

XANAFLU 2025-2026 suspension for injection pre-filled syringe mit needle was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.